Cargando…

An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies

BACKGROUND: Congenital muscular dystrophies (CMDs) result from genetically inherited defects in the biosynthesis and/or the posttranslational modification (glycosylation) of laminin-α2 and α-dystroglycan (α-DG), respectively. The interaction between both proteins is responsible for the stability and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabry, Sahar, Issa, Mahmoud Y, Abdel-Hamid, Mohamed S, Eissa, Noura R, Abdel-Ghafar, Sherif F, Ibrahim, Mona M, Zaki, Maha S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374774/ https://www.ncbi.nlm.nih.gov/pubmed/37318662 http://dx.doi.org/10.1007/s11033-023-08500-7

Ejemplares similares

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
por: Saito, Fumiaki, et al.
Publicado: (2011)

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy
por: Okuma, Hidehiko, et al.
Publicado: (2023)

TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy
por: Larson, Austin A., et al.
Publicado: (2018)

High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan
por: Bigotti, Maria Giulia, et al.
Publicado: (2021)

Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy
por: Sciandra, Francesca, et al.
Publicado: (2015)

Loss of α-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE
por: de Bernabé, Daniel Beltrán-Valero, et al.
Publicado: (2009)

LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to α-Dystroglycan Conferring Laminin Binding
por: Zhang, Zhen, et al.
Publicado: (2011)

Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma
por: Beltrán, Daniel, et al.
Publicado: (2019)

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
por: Pane, M., et al.
Publicado: (2012)

α-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability
por: Montanaro, Federica, et al.
Publicado: (1999)

Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
por: Sabry, Sahar, et al.
Publicado: (2023)

Long-term follow-up of laminin α2 (merosin)-deficient muscular dystrophy in a cat
por: Awamura, Yuichi, et al.
Publicado: (2008)

Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Harandi, Vahid M., et al.
Publicado: (2020)

biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies
por: Gumlaw, Nathan, et al.
Publicado: (2020)

The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy
por: Nickolls, Alec R., et al.
Publicado: (2018)

Structural basis of laminin binding to the LARGE glycans on dystroglycan
por: Briggs, David C., et al.
Publicado: (2016)

Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Körner, Zandra, et al.
Publicado: (2016)

Immobilization of Dystrophin and Laminin α2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy
por: Li, Mei, et al.
Publicado: (2015)

Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases
por: Nelson, Isabelle, et al.
Publicado: (2015)

Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies
por: Stevens, Elizabeth, et al.
Publicado: (2013)

Structural flexibility of human α‐dystroglycan
por: Covaceuszach, Sonia, et al.
Publicado: (2017)

A Splice Site Mutation in Laminin-α2 Results in a Severe Muscular Dystrophy and Growth Abnormalities in Zebrafish
por: Gupta, Vandana A., et al.
Publicado: (2012)

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
por: Nguyen, Quynh, et al.
Publicado: (2019)

Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy
por: Willmann, Raffaella, et al.
Publicado: (2017)

Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
por: Wuebbles, Ryan D., et al.
Publicado: (2013)

Natural disease history of the dy(2J) mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy
por: Pasteuning-Vuhman, S., et al.
Publicado: (2018)

Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin α2-related muscular dystrophy
por: Ge, Lin, et al.
Publicado: (2018)

Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan
por: Chandel, Ishita, et al.
Publicado: (2023)

Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
por: Mehuron, Thomas, et al.
Publicado: (2014)

M. leprae interacts with the human epidermal keratinocytes, neonatal (HEKn) via the binding of laminin-5 with α-dystroglycan, integrin-β1, or -β4
por: Jin, Song-Hyo, et al.
Publicado: (2019)

Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
por: Duclos, Franck, et al.
Publicado: (1998)

Laminin-induced Clustering of Dystroglycan on Embryonic Muscle Cells: Comparison with Agrin-induced Clustering
por: Cohen, Monroe W., et al.
Publicado: (1997)

Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy
por: Gawlik, Kinga I., et al.
Publicado: (2017)

Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy
por: Yatsenko, Andriy S., et al.
Publicado: (2020)

Correction: dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
por: Mehuron, Thomas, et al.
Publicado: (2014)

Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
por: Barraza-Flores, Pamela, et al.
Publicado: (2020)

Natural products, PGC-1α, and Duchenne muscular dystrophy
por: Suntar, Ipek, et al.
Publicado: (2020)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Exogenous laminin exhibits a unique vascular pattern in the brain via binding to dystroglycan and integrins
por: Ruan, Jingsong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nqu6790eqjac5boqpqoc4u8km2